These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 27265567)
1. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations. Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones. Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors. Hassanein HH; Georgey HH; Fouad MA; El Kerdawy AM; Said MF Future Med Chem; 2017 Apr; 9(6):553-578. PubMed ID: 28394629 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Alam MJ; Alam O; Khan SA; Naim MJ; Islamuddin M; Deora GS Drug Des Devel Ther; 2016; 10():3529-3543. PubMed ID: 27826185 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole. Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor. Almarsoomi T; Osmaniye D; Sağlık BN; Levent S; Ghani U; Özkay Y; Kaplancıklı ZA J Mol Recognit; 2023 Jul; 36(7):e3025. PubMed ID: 37191245 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship. Hayashi S; Sumi Y; Ueno N; Murase A; Takada J Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371 [TBL] [Abstract][Full Text] [Related]